Old Well Partners, LLC Lian Bio Transaction History

Old Well Partners, LLC

  • $45.6 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Aug 19, 2024
BUY
$1.57 - $2.66 $50,554 - $85,652
32,200 New
32,200 $63,000
Q2 2022

Aug 15, 2022
BUY
$2.15 - $6.01 $27,950 - $78,130
13,000 Added 67.71%
32,200 $70,000
Q1 2022

May 16, 2022
BUY
$2.8 - $6.21 $21,000 - $46,575
7,500 Added 64.1%
19,200 $71,000
Q4 2021

Feb 14, 2022
BUY
$6.14 - $16.2 $71,838 - $189,540
11,700 New
11,700 $72,000

Others Institutions Holding LIAN

# of Institutions
3
Shares Held
1.1M
Call Options Held
0
Put Options Held
0
View Full List

About LianBio

LIAN Quotes by TradingView
  • Ticker LIAN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 108,354,000
  • Market Cap $32.5M
  • Description
  • LianBio, a biopharmaceutical company, engages in developing and commercializing medicines for cardiovascular, oncology, respiratory, opthalmology, and inflammatory diseases in China and other Asian countries. The company develops mavacamten for the treatment of obstructive and non-obstructive hypertrophic cardiomyopathy, and heart failure with p...
More about LIAN
Track This Portfolio

Track Old Well Partners, LLC Portfolio

Follow Old Well Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Old Well Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Old Well Partners, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email